English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

395 5. Shinkawa A, Ueda K, Kiyohara Y et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995; 26: 380–5. 6. Ezekowitz M, James K, Nazarian S et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 1995; 92: 2178–82. 7. Kilander L, Andren B, Nymanet H et al. Atrial fibrillation is an independent determinant of low cognitive function: a crosssectional study in elderly men. Stroke 1998; 29: 1816–20. 8. Sabatini T, Frisoni G, Barbisoni P et al. Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc 2000; 48: 387–90. 9. Ott A, Breteler M, de Bruyne M et al. Atrial fibrillation and dementia in a population-based study: the Rotterdam study. Stroke 1997; 28: 316–21. 10. Farina E, Magni E, Ambrosini F et al. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand 1997; 96: 310–16. 11. Stanley TO, Mackensen B, Grocott H et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002; 94: 290–5. 12. Sudlow M, Thomson R, Thwaites B et al. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167–71. 13. O’Connell J, Gray C, French J et al. Atrial fibrillation and cognitive function: case-control study. J Neurol Neurosurg Psychiatry 1998; 65: 386–9. 14. Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30: 473–83. 15. Stanford/VA Alzheimer’s Disease Research Center, Geriatric Depression Scale 2003. 16. Agüero-Torres H, Fratiglioni L, Guo Z et al. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol 1999; 58: 737–48. 17. Eagles J, Beattie J, Restall D et al. Relation between cognitive impairment and early death in the elderly. BMJ 1990; 300: 239–40. 18. Gussekloo J, Westendorp R, Remarque E et al. Impact of mild cognitive impairment on survival in very elderly people: cohort study. BMJ 1997; 315: 1053–4. 19. Brayne C, Best N, Muir M et al. Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70–79 at baseline. Int J Geriatr Psychiatry 1997; 12: 1107–18. 20. O’Brien JT, Erkinjuntti T, Reisberg B. Vascular cognitive impairment. Lancet 2003; 2: 89–98. 21. Elias MF, Sullivan LM, D’Agostino RB et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004; 35: 404–9.

Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age